SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-048452
Filing Date
2015-02-13
Accepted
2015-02-13 08:42:01
Documents
7
Period of Report
2015-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d873373d8k.htm 8-K 17463
2 EX-1.1 d873373dex11.htm EX-1.1 143153
3 EX5.1 d873373dex51.htm EX-5.1 8739
4 EX-99.1 d873373dex991.htm EX-99.1 5480
5 GRAPHIC g873373img001.jpg GRAPHIC 2637
6 GRAPHIC g873373img002.jpg GRAPHIC 14519
7 GRAPHIC g873373img003.jpg GRAPHIC 14676
  Complete submission text file 0001193125-15-048452.txt   220363
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 15609198
SIC: 2836 Biological Products, (No Diagnostic Substances)